Sanofi
SNYNF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $13 | $11 | $11 | $11 |
| % Growth | 22.7% | 1.2% | -7.1% | – |
| Cost of Goods Sold | $3 | $3 | $3 | $2 |
| Gross Profit | $10 | $8 | $8 | $8 |
| % Margin | 74.1% | 72.1% | 72.8% | 68.7% |
| R&D Expenses | $2 | $2 | $2 | $2 |
| G&A Expenses | $0 | -$2 | $0 | $0 |
| SG&A Expenses | $2 | $3 | $2 | $1 |
| Sales & Mktg Exp. | $0 | $5 | $0 | $0 |
| Other Operating Expenses | $2 | $2 | $1 | $1 |
| Operating Expenses | $6 | $6 | $5 | $5 |
| Operating Income | $4 | $1 | $2 | $1 |
| % Margin | 27.5% | 13.7% | 21.5% | 10.4% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | $4 | $1 | $2 | $1 |
| Tax Expense | $1 | $0 | $0 | $0 |
| Net Income | $3 | $4 | $2 | $1 |
| % Margin | 21.3% | 36.7% | 17.7% | 6% |
| EPS | 2.3 | 3.19 | 1.52 | 0.4 |
| % Growth | -27.9% | 109.9% | 280% | – |
| EPS Diluted | 2.27 | 3.19 | 1.52 | 0.4 |
| Weighted Avg Shares Out | 1 | 1 | 1 | 1 |
| Weighted Avg Shares Out Dil | 1 | 1 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $4 | $2 | $3 | $1 |
| % Margin | 32% | 17.6% | 26.1% | 4.9% |